This post was originally published on this site
https://i-invdn-com.investing.com/news/LYNXNPEC1N1CU_M.jpg
Kenvue, which trades under the ticker “KVUE,” opened at $25.53 a share, up 17% and well above its original initial public offering price of $22 seen Wednesday.
Johnson & Johnson (NYSE:JNJ) continues to hold a 91.9% stake in Kenvue, which sells a range of well known consumer health brands including Band Aid, Listerine, Tylenol, Johnson’s baby products, among others.
J&J announced plans to spinoff its consumer health business in November 2021 as it looked to streamline its business and focus on developing medicines and medical devices.
